当前位置:首页 - 行情中心 - 辰光医疗(920300) - 财务分析 - 现金流量表

辰光医疗

(920300)

  

流通市值:10.72亿  总市值:13.83亿
流通股本:6653.17万   总股本:8584.71万

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金100,703,521.5867,672,959.9929,583,306.02152,687,808.39
  收到的税费返还52,969.852,969.852,969.8-
  收到其他与经营活动有关的现金612,602.531,521,811.74764,186.73,047,327.45
  经营活动现金流入小计101,369,093.9169,247,741.5330,400,462.52155,735,135.84
  购买商品、接受劳务支付的现金30,943,50728,321,462.7116,390,347.1792,828,207.53
  支付给职工以及为职工支付的现金41,108,145.9529,127,913.8415,987,505.0566,160,101.71
  支付的各项税费3,171,068.751,987,871.47699,873.983,829,671.73
  支付其他与经营活动有关的现金17,518,134.2210,926,982.825,520,092.2321,401,630.31
  经营活动现金流出小计92,740,855.9270,364,230.8438,597,818.43184,219,611.28
  经营活动产生的现金流量净额8,628,237.99-1,116,489.31-8,197,355.91-28,484,475.44
二、投资活动产生的现金流量:
  收回投资收到的现金88,000,00060,000,00016,000,00088,000,000
  取得投资收益收到的现金239,046.87126,820.8419,239.45695,523.34
  处置固定资产、无形资产和其他长期资产收回的现金净额---7,100
  投资活动现金流入小计88,239,046.8760,126,820.8416,019,239.4588,702,623.34
  购建固定资产、无形资产和其他长期资产支付的现金1,845,836.591,164,531.65802,279.318,665,071.37
  投资支付的现金88,000,00080,000,00036,000,00088,000,000
  投资活动现金流出小计89,845,836.5981,164,531.6536,802,279.3106,665,071.37
  投资活动产生的现金流量净额-1,606,789.72-21,037,710.81-20,783,039.85-17,962,448.03
三、筹资活动产生的现金流量:
  取得借款收到的现金96,000,00046,000,00012,000,000140,250,000
  筹资活动现金流入小计96,000,00046,000,00012,000,000140,250,000
  偿还债务支付的现金100,269,90047,150,0008,500,000122,550,000
  分配股利、利润或偿付利息支付的现金3,282,317.092,195,055.651,092,631.524,261,057.23
  支付其他与筹资活动有关的现金2,251,722.51,531,722.5-2,917,771.92
  筹资活动现金流出小计105,803,939.5950,876,778.159,592,631.52129,728,829.15
  筹资活动产生的现金流量净额-9,803,939.59-4,876,778.152,407,368.4810,521,170.85
四、汇率变动对现金及现金等价物的影响16,681.486,277.7635,072.57182,724.07
五、现金及现金等价物净增加额-2,765,809.84-27,024,700.51-26,537,954.71-35,743,028.55
  加:期初现金及现金等价物余额52,529,011.3552,529,011.3552,829,011.3588,272,039.9
  期末现金及现金等价物余额49,763,201.5125,504,310.8426,291,056.6452,529,011.35
补充资料:
  净利润--14,817,670.78--60,898,635.5
  资产减值准备-1,394,339.31-22,098,174.01
  固定资产和投资性房地产折旧-5,020,978.06-9,271,791.44
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-5,020,978.06-9,271,791.44
  无形资产摊销-2,522,310.67-6,641,911.58
  长期待摊费用摊销-1,366,055.02-2,036,327.7
  处置固定资产、无形资产和其他长期资产的损失---72,912.53
  财务费用-2,590,091.06-5,015,933.67
  投资损失--126,820.84--695,523.34
  递延所得税--3,736,702.87--7,765,339.44
  其中:递延所得税资产减少--3,736,702.87--7,765,339.44
  存货的减少--504,920.57--36,686,009.33
  经营性应收项目的减少-12,373,615.65-12,713,127.94
  经营性应付项目的增加--6,961,720.31-11,298,857.57
  不涉及现金收支的投资和筹资活动金额其他项目---128,564.96
  现金的期末余额-25,504,310.84-52,529,011.35
  减:现金的期初余额-52,529,011.35-88,272,039.9
  现金及现金等价物的净增加额--27,024,700.51--35,743,028.55
公告日期2025-10-302025-08-282025-04-292025-04-25
审计意见(境内)标准无保留意见
TOP↑